Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

An epigenetic mechanism for capecitabine resistance in mesothelioma

25 Dec 2009

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Diagnosis and Treatment
Share to Medical Imaging and Pathology Studies
Share to Occupational and environmental lung diseases

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 20035722
DOI: 10.1016/j.bbrc.2009.12.095

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

An epigenetic mechanism for capecitabine resistance in mesotheliomaPMID 20035722Read ↗

The role of epigenetics in malignant pleural mesotheliomaSemantic proximity Read ↗

Molecular Resistance Fingerprint of Pemetrexed and Platinum in a Long-Term Survivor of MesotheliomaSemantic proximity Read ↗

Critical review about MDM2 in cancer: Possible role in malignant mesothelioma and implications for treatmentSemantic proximity Read ↗

Cellular irinotecan resistance in colorectal cancer and overcoming irinotecan refractoriness through various combination trials including DNA methyltransferase inhibitors: a reviewSemantic proximity Read ↗

Role of proton-coupled folate transporter in pemetrexed resistance of mesothelioma: clinical evidence and new pharmacological toolsSemantic proximity Read ↗

The influence of platinum pathway polymorphisms on the outcome in patients with malignant mesotheliomaSemantic proximity Read ↗

ERCC1, MLH1, MSH2, MSH6, and βIII-Tubulin: Resistance Proteins Associated With Response and Outcome to Platinum-based Chemotherapy in Malignant Pleural MesotheliomaSemantic proximity Read ↗

Mutations linked to chemotherapy resistance in colorectal cancer.Semantic proximity Read ↗

Epigenetic changes in histone acetylation underpin resistance to the topoisomerase I inhibitor irinotecanSemantic proximity Read ↗

Aberrant methylation of the ATM promoter correlates with increased radiosensitivity in a human colorectal tumor cell lineSemantic proximity Read ↗

Chemotherapy of MMR-deficient colorectal cancerSemantic proximity Read ↗

Upregulation of Thymidylate Synthase Induces Pemetrexed Resistance in Malignant Pleural MesotheliomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.